BioSpace News Archive

STERIS plc announced that it will host a conference call to discuss its fiscal 2020 fourth quarter and full year financial results at 10:00 a.m. Eastern Time on Thursday, May 14, 2020.

First Quarter TIBSOVO® Net Revenue of $22.7 Million; Company Reiterates 2020 TIBSOVO® Net U.S. Revenue Guidance of $105–115 Million

Concert Pharmaceuticals, Inc. reported financial results for the first quarter of 2020..

BAFIERTAM™ (monomethyl fumarate), the bioequivalent alternative to Biogen’s Tecfidera® (dimethyl fumarate), is a new oral treatment option for relapsing forms of multiple sclerosis

Marinus Pharmaceuticals, Inc. announced the formation of a Scientific Advisory Board with the appointment of six leading experts in clinical neurology and seizure disorders: Jacqueline French, M.D., Lawrence Hirsch, M.D., Aatif Husain, M.D., Michael Rogawski M.D., Ph.D., Eugen Trinka, M.D. and Henrikas Vaitkevicius, M.D.

Company Supports Investigator-Initiated Study of Brensocatib (Formerly INS1007) in Severe COVID-19 and Continues to Advance Development in Bronchiectasis

Dry Eye Disease Phase 2 Study Remains on Track - Data Anticipated in 4Q20

Torben Jørgensen, Chairman of the Board in Biotage AB, informed the company that he has sold part of his shareholding in Biotage on 29 April 2020.

AlzeCure Pharma AB and Karolinska Intitutet have had a long-term collaboration in the CNS field, and their joint doctoral student Märta Dahlström is defending her doctoral thesis at a public dissertation at Karolinska Institutet.

Transparency Market Research has published a new report on the varicose vein treatment market.